Table 4.
Reported Symptoms Prior to Serology Testing
| Symptom | Seropositive (N=95), No. (%) |
Seronegative (N=10,309), No. (%) |
Odds Ratio (95% CI)a |
|---|---|---|---|
| Any symptoms | 41 (43.2) | 3,344 (32.4) | 1.58 (1.03–2.42) |
| Congestion | 19 (20.0) | 1,673 (16.2) | 1.29 (0.73–2.16) |
| Sore throat | 18 (18.9) | 1,615 (15.7) | 1.26 (0.71–2.13) |
| Cough or shortness of breath | 22 (23.2) | 1,506 (14.6) | 1.76 (1.04–2.13) |
| Headache | 21 (22.1) | 1,407 (13.6) | 1.80 (1.05–3.00) |
| Fatigue | 20 (21.1) | 1,209 (11.7) | 2.01 (1.16–3.34) |
| Fever or chills | 19 (20.0) | 910 (8.8) | 2.58 (1.47–4.34) |
| Muscle aches | 20 (21.1) | 899 (8.7) | 2.79 (1.61–4.65) |
| Nausea, vomiting, diarrhea | 7 (7.4) | 571 (5.5) | 1.36 (0.53–2.93) |
| Other symptoms | 5 (5.3) | 82 (0.8) | 6.92 (2.14–17.43) |
| Thought they had COVID-19 prior to serologic testing | 28 (29.5) | 1,161 (11.3) | 3.29 (2.03–5.21) |
Note. This table includes the exact list of symptoms asked of HCP in the survey. Individuals could select multiple symptoms. Prior symptoms included any symptoms between February 1, 2020 and the time of serologic testing in April or May 2020.
a
Univariate analysis was performed using the Fisher exact test and significant results are indicated in bold.